TY - JOUR
T1 - Impact of nodal involvement on surgical outcomes of intrahepatic cholangiocarcinoma
T2 - A multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery
AU - Uchiyama, Kazuhisa
AU - Yamamoto, Masakazu
AU - Yamaue, Hiroki
AU - Ariizumi, Shun Ichi
AU - Aoki, Taku
AU - Kokudo, Norihiro
AU - Ebata, Tomoki
AU - Nagino, Masato
AU - Ohtsuka, Masayuki
AU - Miyazaki, Masaru
AU - Tanaka, Eiichi
AU - Kondo, Satoshi
AU - Uenishi, Takahiro
AU - Kubo, Shoji
AU - Yoshida, Hiroshi
AU - Unno, Michiaki
AU - Imura, Satoru
AU - Shimada, Mitsuo
AU - Ueno, Masaki
AU - Takada, Tadahiro
PY - 2011/5
Y1 - 2011/5
N2 - Background/purpose: The aim of this study was to clarify the prognostic factors of intrahepatic cholangiocarcinoma (ICC) following hepatectomy and to examine the impact of lymph node metastasis on survival. This study was therefore carried out as a Project Study of the Japanese Society of Hepato-Biliary-Pancreatic Surgery. Methods: Three hundred and forty-one patients who underwent hepatectomy for ICC between 1995 and 2004 at the 9 institutions of the Medical University Hospitals were analyzed retrospectively. Multivariate regression analyses and a Kaplan-Meyer analysis were performed to identify prognostic factors. Results: Pathological lymph node metastasis was one of the significant factors affecting overall survival (hazard ratio 2.10, p < 0.001) based on the multivariate analysis. Among the patients who underwent extended lymphadenectomy beyond the hepatoduodenal ligament, the median survival of 121 patients with nodal involvement was 12.2 months. Only seven patients with nodal involvement have survived for more than 4 years. Conclusions: In the present study, preoperative carbohydrate antigen (CA) 19-9, intrahepatic metastasis, and nodal involvement were the significant independent predictors of poor prognosis by multivariate analysis. Further prospective studies may thus be needed to confirm these findings, because this study has a limitation in that it was a retrospective study with multicenter data collection.
AB - Background/purpose: The aim of this study was to clarify the prognostic factors of intrahepatic cholangiocarcinoma (ICC) following hepatectomy and to examine the impact of lymph node metastasis on survival. This study was therefore carried out as a Project Study of the Japanese Society of Hepato-Biliary-Pancreatic Surgery. Methods: Three hundred and forty-one patients who underwent hepatectomy for ICC between 1995 and 2004 at the 9 institutions of the Medical University Hospitals were analyzed retrospectively. Multivariate regression analyses and a Kaplan-Meyer analysis were performed to identify prognostic factors. Results: Pathological lymph node metastasis was one of the significant factors affecting overall survival (hazard ratio 2.10, p < 0.001) based on the multivariate analysis. Among the patients who underwent extended lymphadenectomy beyond the hepatoduodenal ligament, the median survival of 121 patients with nodal involvement was 12.2 months. Only seven patients with nodal involvement have survived for more than 4 years. Conclusions: In the present study, preoperative carbohydrate antigen (CA) 19-9, intrahepatic metastasis, and nodal involvement were the significant independent predictors of poor prognosis by multivariate analysis. Further prospective studies may thus be needed to confirm these findings, because this study has a limitation in that it was a retrospective study with multicenter data collection.
KW - CA19-9
KW - Extended lymph node dissection
KW - Intrahepatic metastasis
KW - Lymph node metastasis
KW - Overall survival
KW - Surgical margin
UR - http://www.scopus.com/inward/record.url?scp=79958274695&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79958274695&partnerID=8YFLogxK
U2 - 10.1007/s00534-010-0349-2
DO - 10.1007/s00534-010-0349-2
M3 - Article
C2 - 21132443
AN - SCOPUS:79958274695
SN - 1868-6974
VL - 18
SP - 443
EP - 452
JO - Journal of Hepato-Biliary-Pancreatic Sciences
JF - Journal of Hepato-Biliary-Pancreatic Sciences
IS - 3
ER -